Skip to main content

Rhonda M. Chicko

Equibles does not estimate personal net worth.

About Rhonda M. Chicko

Earlier roles on record: CFO at Korsana Biosciences, Inc. (KRSA) until September 8, 2026. Korsana Biosciences, Inc. reported in an 8-K filed September 11, 2026 that Rhonda M. Chicko resigned as Chief Financial Officer, effective September 8, 2026. Rhonda M. Chicko has spoken on 1 investor event across 1 company, most recently for Korsana Biosciences, Inc. on April 1, 2026. The companies whose calls Rhonda M. Chicko spoke on are classified in the Healthcare sector.

“In addition, on September 8, 2026, Regina M. Graul, Ph.D., Cyclerion’s President and Chief Executive Officer, and Rhonda M. Chicko, Cyclerion’s Chief Financial Officer, each resigned as an executive officer of the Company at the Closing.”
Korsana Biosciences, Inc. Form 8-K, filed September 11, 2026 · Read the filing

Rhonda M. Chicko on recent calls

“Before we begin, I'd like to remind you that during this call, we may make forward-looking statements.”
CFO, Cyclerion Therapeutics – Korsana Biosciences Merger Agreement Announcement Conference Call ·

Affiliation history

Company network

Recent activity